Selected Papers from International Conference on Nanomedicine and Nanobiotechnology—ICONAN2024

Dear Colleagues,

Nanomedicine and nanobiotechnology have tremendous potential for tomorrow’s patient care, particularly in cancer disease management. This Special Issue of Cancers aims to gather the numerous theoretical and research concepts in nanomedicine that are currently being translated into preclinical and clinical studies. This Special Issue is based on the fifth edition of the ICONAN conference, which will bring together high-profile plenary speakers and world-class researchers who have successfully developed and translated nanomedicines over the last decades. The use of nanomedicine/nanobiotechnology for imaging, diagnosis, biosensing, drug delivery, therapy, or any other use of nanotechnologies in relation with cancer and health are welcome.

Prof. Dr. Anne-Marie Caminade
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanomedicine
• nanobiotechnology
• nanodevices
• nanoimaging
• 3D models
• drug delivery
• nanotechnologies for translational medicine
• pre-clinical and clinical phases
• from bench to bedside